|
1
|
Widysanto A, Combest FE, Dhakal A and
Saadabadi A: Nicotine addiction (Updated 2023 Aug 8). StatPearls
[Internet]. StatPearls Publishing; Treasure Island, FL: 2024
|
|
2
|
Prochaska JJ and Benowitz NL: Current
advances in research in treatment and recovery: Nicotine addiction.
Sci Adv. 5:eaay97632019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Onaolapo OJ and Onaolapo AY: Melatonin in
drug addiction and addiction management: Exploring an evolving
multidimensional relationship. World J Psychiatry. 8:64–74. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Picciotto MR and Kenny PJ: Mechanisms of
nicotine addiction. Cold Spring Harb Perspect Med. 11:a0396102021.
View Article : Google Scholar
|
|
5
|
Zhu J, Nelson K, Toth J and Muscat JE:
Nicotine dependence as an independent risk factor for
atherosclerosis in the national lung screening trial. BMC Public
Health. 19:1032019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Trakas N, Georgakopoulou VE, Melemeni D,
Damaskos C, Mantzouranis K, Garmpis N, Gkoufa A, Papalexis P,
Chlapoutakis S, Sklapani P, et al: Association between smoking
cessation and alterations in forced expiratory volume in one second
(FEV1). A follow-up study from a greek tobacco cessation clinic.
Addict Health. 14:87–95. 2022.PubMed/NCBI
|
|
7
|
Masters A, Pandi-Perumal SR, Seixas A,
Girardin JL and McFarlane SI: Melatonin, the hormone of darkness:
From sleep promotion to ebola treatment. Brain Disord Ther.
4:10001512014.
|
|
8
|
Hardeland R, Madrid JA, Tan DX and Reiter
RJ: Melatonin, the circadian multioscillator system and health: The
need for detailed analyses of peripheral melatonin signaling. J
Pineal Res. 52:139–166. 2012. View Article : Google Scholar
|
|
9
|
Tan DX, Manchester LC, Esteban-Zubero E,
Zhou Z and Reiter RJ: Melatonin as a potent and inducible
endogenous antioxidant: Synthesis and metabolism. Molecules.
20:18886–18906. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reiter RJ, Rosales-Corral SA, Tan DX,
Acuna-Castroviejo D, Qin L, Yang SF and Xu K: Melatonin, a full
service anti-cancer agent: Inhibition of initiation, progression
and metastasis. Int J Mol Sci. 18:8432017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bocheva G, Slominski RM, Janjetovic Z, Kim
TK, Böhm M, Steinbrink K, Reiter RJ, Kleszczyński K and Slominski
AT: Protective role of melatonin and its metabolites in skin aging.
Int J Mol Sci. 23:12382022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lempesis IG, Georgakopoulou VE, Reiter RJ
and Spandidos DA: A mid-pandemic night's dream: Melatonin, from
harbinger of anti-inflammation to mitochondrial savior in acute and
long COVID-19 (Review). Int J Mol Med. 53:282024. View Article : Google Scholar :
|
|
13
|
Horton WJ, Gissel HJ, Saboy JE, Wright KP
Jr and Stitzel JA: Melatonin administration alters nicotine
preference consumption via signaling through high-affinity
melatonin receptors. Psychopharmacology (Berl). 232:2519–2530.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schiller ED, Champney TH, Reiter CK and
Dohrman DP: Melatonin inhibition of nicotine-stimulated dopamine
release in PC12 cells. Brain Res. 966:95–102. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Markus RP, Santos JM, Zago W and Reno LA:
Melatonin nocturnal surge modulates nicotinic receptors and
nicotine-induced [3H]glutamate release in rat cerebellum slices. J
Pharmacol Exp Ther. 305:525–530. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Guo D, Wang J, Tian B, Li Y, Sun G
and Zhang H: Exogenous melatonin alleviates NO2 damage
in tobacco leaves by promoting antioxidant defense, modulating
redox homeostasis, and signal transduction. J Hazard Mater.
424:1272652022. View Article : Google Scholar
|
|
17
|
Zhdanova IV and Piotrovskaya VR: Melatonin
treatment attenuates symptoms of acute nicotine withdrawal in
humans. Pharmacol Biochem Behav. 67:131–135. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Acuña-Castroviejo D, Escames G, Venegas C,
Díaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan DX
and Reiter RJ: Extrapineal melatonin: Sources, regulation, and
potential functions. Cell Mol Life Sci. 71:2997–3025. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pandi-Perumal SR, Srinivasan V, Maestroni
GJ, Cardinali DP, Poeggeler B and Hardeland R: Melatonin: Nature's
most versatile biological signal? FEBS J. 273:2813–2838. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie X, Ding D, Bai D, Zhu Y, Sun W, Sun Y
and Zhang D: Melatonin biosynthesis pathways in nature and its
production in engineered microorganisms. Synth Syst Biotechnol.
7:544–553. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z,
Sharma R and Reiter RJ: Melatonin synthesis and function:
evolutionary history in animals and plants. Front Endocrinol
(Lausanne). 10:2492019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zisapel N: New perspectives on the role of
melatonin in human sleep, circadian rhythms and their regulation.
Br J Pharmacol. 175:3190–3199. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Blume C, Garbazza C and Spitschan M:
Effects of light on human circadian rhythms, sleep and mood.
Somnologie (Berl). 23:147–156. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chitimus DM, Popescu MR, Voiculescu SE,
Panaitescu AM, Pavel B, Zagrean L and Zagrean AM: Melatonin's
impact on antioxidative and anti-inflammatory reprogramming in
homeostasis and disease. Biomolecules. 10:12112020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kopustinskiene DM and Bernatoniene J:
Molecular mechanisms of melatonin-mediated cell protection and
signaling in health and disease. Pharmaceutics. 13:1292021.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carrillo-Vico A, Reiter RJ, Lardone PJ,
Herrera JL, Fernández-Montesinos R, Guerrero JM and Pozo D: The
modulatory role of melatonin on immune responsiveness. Curr Opin
Investig Drugs. 7:423–431. 2006.PubMed/NCBI
|
|
27
|
Calvo JR, González-Yanes C and Maldonado
MD: The role of melatonin in the cells of the innate immunity: A
review. J Pineal Res. 55:103–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carrillo-Vico A, Lardone PJ,
Alvarez-Sánchez N, Rodríguez-Rodríguez A and Guerrero JM:
Melatonin: Buffering the immune system. Int J Mol Sci.
14:8638–8683. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JG, Woo YS, Park SW, Seog DH, Seo MK
and Bahk WM: The neuroprotective effects of melatonin: Possible
role in the pathophysiology of neuropsychiatric disease. Brain Sci.
9:2852019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Won E, Na KS and Kim YK: Associations
between melatonin, neuroinflammation, and brain alterations in
depression. Int J Mol Sci. 23:3052021. View Article : Google Scholar
|
|
31
|
Tozihi M, Shademan B, Yousefi H, Avci CB,
Nourazarian A and Dehghan G: Melatonin: A promising neuroprotective
agent for cerebral ischemia-reperfusion injury. Front Aging
Neurosci. 15:12275132023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Srinivasan V, Pandi-Perumal SR, Cardinali
DP, Poeggeler B and Hardeland R: Melatonin in Alzheimer's disease
and other neurodegenerative disorders. Behav Brain Funct. 2:152006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reiter RJ, Tamura H, Tan DX and Xu XY:
Melatonin and the circadian system: Contributions to successful
female reproduction. Fertil Steril. 102:321–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aversa S, Pellegrino S, Barberi I, Reiter
RJ and Gitto E: Potential utility of melatonin as an antioxidant
during pregnancy and in the perinatal period. J Matern Fetal
Neonatal Med. 25:207–221. 2012. View Article : Google Scholar
|
|
35
|
Olcese JM: Melatonin and female
reproduction: An expanding universe. Front Endocrinol (Lausanne).
11:852020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Benowitz NL: Pharmacology of nicotine:
Addiction, smoking-induced disease, and therapeutics. Annu Rev
Pharmacol Toxicol. 49:57–71. 2009. View Article : Google Scholar
|
|
37
|
De Biasi M and Dani JA: Reward, addiction,
withdrawal to nicotine. Annu Rev Neurosci. 34:105–130. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Chen X, Gong J and Yan Y:
Relationships between stress, negative emotions, resilience, and
smoking: Testing a moderated mediation model. Subst Use Misuse.
51:427–438. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Stevenson JG, Oliver JA, Hallyburton MB,
Sweitzer MM, Conklin CA and McClernon FJ: Smoking environment cues
reduce ability to resist smoking as measured by a delay to smoking
task. Addict Behav. 67:49–52. 2017. View Article : Google Scholar :
|
|
40
|
Roy A, Rawal I, Jabbour S and Prabhakaran
D: Chapter 4: Tobacco and cardiovascular disease: A summary of
evidence. Cardiovascular Respiratory, and Related Disorders.
Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y and Nugent R:
3rd edition. The International Bank for Reconstruction and
Development/The World Bank; Washington, DC: 2017
|
|
41
|
Liu CC and Yeh HI: Nicotine: A
double-edged sword in atherosclerotic disease. Acta Cardiol Sin.
30:108–113. 2014.PubMed/NCBI
|
|
42
|
Benowitz NL and Burbank AD: Cardiovascular
toxicity of nicotine: Implications for electronic cigarette use.
Trends Cardiovasc Med. 26:515–523. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Strzelak A, Ratajczak A, Adamiec A and
Feleszko W: Tobacco smoke induces and alters immune responses in
the lung triggering inflammation, allergy, asthma and other lung
diseases: A mechanistic review. Int J Environ Res Public Health.
15:10332018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mishra A, Chaturvedi P, Datta S, Sinukumar
S, Joshi P and Garg A: Harmful effects of nicotine. Indian J Med
Paediatr Oncol. 36:24–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Grando SA: Connections of nicotine to
cancer. Nat Rev Cancer. 14:419–429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Caliri AW, Tommasi S and Besaratinia A:
Relationships among smoking, oxidative stress, inflammation,
macromolecular damage, and cancer. Mutat Res Rev Mutat Res.
787:1083652021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chang CM, Corey CG, Rostron BL and
Apelberg BJ: Systematic review of cigar smoking and all cause and
smoking related mortality. BMC Public Health. 15:3902015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim AS, Ko HJ, Kwon JH and Lee JM:
Exposure to secondhand smoke and risk of cancer in never smokers: A
meta-analysis of epidemiologic studies. Int J Environ Res Public
Health. 15:19812018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
El-Sherbiny NA and Elsary AY: Smoking and
nicotine dependence in relation to depression, anxiety, and stress
in Egyptian adults: A cross-sectional study. J Family Community
Med. 29:8–16. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kutlu MG, Parikh V and Gould TJ: Nicotine
addiction and psychiatric disorders. Int Rev Neurobiol.
124:171–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Albarrak DA, Alotaibi AB, Alotaibi RF,
Alramadhan SH, Bin Muhanna AI, Aldehan AM and Bin Abdulrahman KA:
The association between nicotine dependence and mental health in
the general population of Saudi Arabia: A cross-sectional
analytical study. Int J Gen Med. 16:5801–5815. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cecon E, Oishi A and Jockers R: Melatonin
receptors: Molecular pharmacology and signalling in the context of
system bias. Br J Pharmacol. 175:3263–3280. 2018. View Article : Google Scholar :
|
|
53
|
Doghramji K: Melatonin and its receptors:
A new class of sleep-promoting agents. J Clin Sleep Med. 3(Suppl
5): S17–S23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Healy KL, Morris AR and Liu AC: Circadian
synchrony: Sleep, nutrition, and physical activity. Front Netw
Physiol. 1:7322432021. View Article : Google Scholar
|
|
55
|
Sato TK, Yamada RG, Ukai H, Baggs JE,
Miraglia LJ, Kobayashi TJ, Welsh DK, Kay SA, Ueda HR and Hogenesch
JB: Feedback repression is required for mammalian circadian clock
function. Nat Genet. 38:312–319. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
56
|
Rahman SA, St Hilaire MA, Chang AM, Santhi
N, Duffy JF, Kronauer RE, Czeisler CA, Lockley SW and Klerman EB:
Circadian phase resetting by a single short-duration light
exposure. JCI Insight. 2:e894942017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Schwartz MD and Kilduff TS: The
neurobiology of sleep and wakefulness. Psychiatr Clin North Am.
38:615–644. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wright KP, Lowry CA and Lebourgeois MK:
Circadian and wakefulness-sleep modulation of cognition in humans.
Front Mol Neurosci. 5:502012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Valdés-Tovar M, Estrada-Reyes R,
Solís-Chagoyán H, Argueta J, Dorantes-Barrón AM, Quero-Chávez D,
Cruz-Garduño R, Cercós MG, Trueta C, Oikawa-Sala J, et al:
Circadian modulation of neuroplasticity by melatonin: A target in
the treatment of depression. Br J Pharmacol. 175:3200–3208. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Boiko DI, Shkodina AD, Hasan MM, Bardhan
M, Kazmi SK, Chopra H, Bhutra P, Baig AA and Skrypnikov AM:
Melatonergic receptors (Mt1/Mt2) as a potential additional target
of novel drugs for depression. Neurochem Res. 47:2909–2924. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mehraein F, Talebi R, Jameie B, Joghataie
MT and Madjd Z: Neuroprotective effect of exogenous melatonin on
dopaminergic neurons of the substantia nigra in ovariectomized
rats. Iran Biomed J. 15:44–50. 2011.PubMed/NCBI
|
|
62
|
Shukla M, Govitrapong P, Boontem P, Reiter
RJ and Satayavivad J: Mechanisms of melatonin in alleviating
Alzheimer's disease. Curr Neuropharmacol. 15:1010–1031. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kim J, Li W, Wang J, Baranov SV, Heath BE,
Jia J, Suofu Y, Baranova OV, Wang X, Larkin TM, et al: Biosynthesis
of neuroprotective melatonin is dysregulated in Huntington's
disease. J Pineal Res. 75:e129092023. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Laudon M and Frydman-Marom A: Therapeutic
effects of melatonin receptor agonists on sleep and comorbid
disorders. Int J Mol Sci. 15:15924–15950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kostoglou-Athanassiou I: Therapeutic
applications of melatonin. Ther Adv Endocrinol Metab. 4:13–24.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Scofield MD, Heinsbroek JA, Gipson CD,
Kupchik YM, Spencer S, Smith ACW, Roberts-Wolfe D and Kalivas PW:
The nucleus accumbens: Mechanisms of addiction across drug classes
reflect the importance of glutamate homeostasis. Pharmacol Rev.
68:816–871. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ekmekcioglu C: Melatonin receptors in
humans: Biological role and clinical relevance. Biomed
Pharmacother. 60:97–108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Leeboonngam T, Pramong R, Sae-Ung K,
Govitrapong P and Phansuwan-Pujito P: Neuroprotective effects of
melatonin on amphetamine-induced dopaminergic fiber degeneration in
the hippocampus of postnatal rats. J Pineal Res. 64:e124562018.
View Article : Google Scholar
|
|
69
|
Sae-Ung K, Uéda K, Govitrapong P and
Phansuwan-Pujito P: Melatonin reduces the expression of
alpha-synuclein in the dopamine containing neuronal regions of
amphetamine-treated postnatal rats. J Pineal Res. 52:128–137. 2012.
View Article : Google Scholar
|
|
70
|
Quintero GC: Role of nucleus accumbens
glutamatergic plasticity in drug addiction. Neuropsychiatr Dis
Treat. 9:1499–1512. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Evely KM, Hudson RL, Dubocovich ML and
Haj-Dahmane S: Melatonin receptor activation increases
glutamatergic synaptic transmission in the rat medial lateral
habenula. Synapse. 70:181–186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Wang DD, Jin MF, Zhao DJ and Ni H:
Reduction of mitophagy-related oxidative stress and preservation of
mitochondria function using melatonin therapy in an HT22
hippocampal neuronal cell model of glutamate-induced
excitotoxicity. Front Endocrinol (Lausanne). 10:5502019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wang C, An Y, Xia Z, Zhou X, Li H, Song S,
Ding L and Xia X: The neuroprotective effect of melatonin in
glutamate excitotoxicity of R28 cells and mouse retinal ganglion
cells. Front Endocrinol (Lausanne). 13:9861312022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Jia S, Guo X, Chen Z, Li S and Liu XA: The
roles of the circadian hormone melatonin in drug addiction.
Pharmacol Res. 183:1063712022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Li X and Slesinger PA: GABAB
receptors and drug addiction: Psychostimulants and other drugs of
abuse. Curr Top Behav Neurosci. 52:119–155. 2022. View Article : Google Scholar
|
|
76
|
Kalsbeek A, Garidou ML, Palm IF, Van Der
Vliet J, Simonneaux V, Pévet P and Buijs RM: Melatonin sees the
light: Blocking GABA-ergic transmission in the paraventricular
nucleus induces daytime secretion of melatonin. Eur J Neurosci.
12:3146–3154. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Cheng XP, Sun H, Ye ZY and Zhou JN:
Melatonin modulates the GABAergic response in cultured rat
hippocampal neurons. J Pharmacol Sci. 119:177–185. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Sari Y, Johnson VR and Weedman JM: Role of
the serotonergic system in alcohol dependence: From animal models
to clinics. Prog Mol Biol Transl Sci. 98:401–443. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Míguez JM, Simonneaux V and Pévet P:
Evidence for a regulatory role of melatonin on serotonin release
and uptake in the pineal gland. J Neuroendocrinol. 7:949–956. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Micale V, Arezzi A, Rampello L and Drago
F: Melatonin affects the immobility time of rats in the forced swim
test: The role of serotonin neurotransmission. Eur
Neuropsychopharmacol. 16:538–545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Befort K: Interactions of the opioid and
cannabinoid systems in reward: Insights from knockout studies.
Front Pharmacol. 6:62015.PubMed/NCBI
|
|
82
|
Fields HL and Margolis EB: Understanding
opioid reward. Trends Neurosci. 38:217–225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Dai X, Cui SG, Li SR, Chen Q and Wang R:
Melatonin attenuates the development of antinociceptive tolerance
to delta-, but not to mu-opioid receptor agonist in mice. Behav
Brain Res. 182:21–27. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
El-Shenawy SM, Abdel-Salam OM, Baiuomy AR,
El-Batran S and Arbid MS: Studies on the anti-inflammatory and
anti-nociceptive effects of melatonin in the rat. Pharmacol Res.
46:235–243. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Van Drunen R and Eckel-Mahan K: Circadian
rhythms of the hypothalamus: From function to physiology. Clocks
Sleep. 3:189–226. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
McLaughlin I, Dani JA and De Biasi M:
Nicotine withdrawal. Curr Top Behav Neurosci. 24:99–123. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Logan RW, Williams WP III and McClung CA:
Circadian rhythms and addiction: Mechanistic insights and future
directions. Behav Neurosci. 128:387–412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hasler BP, Smith LJ, Cousins JC and
Bootzin RR: Circadian rhythms, sleep, and substance abuse. Sleep
Med Rev. 16:67–81. 2012. View Article : Google Scholar
|
|
89
|
Cho YM, Kim HR, Kang MY, Myong JP and Koo
JW: Fixed night workers and failed smoking cessation. J Occup Med
Toxicol. 14:232019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Cardinali DP, Brown GM and Pandi-Perumal
SR: Chronotherapy. Handb Clin Neurol. 179:357–370. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Bae MJ, Song YM, Shin JY, Choi BY, Keum JH
and Lee EA: The association between shift work and health behavior:
Findings from the Korean national health and nutrition examination
survey. Korean J Fam Med. 38:86–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Short NA, Mathes BM, Gibby B, Oglesby ME,
Zvolensky MJ and Schmidt NB: Insomnia symptoms as a risk factor for
cessation failure following smoking treatment. Addict Res Theory.
25:17–23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Perreau-Lenz S and Spanagel R: Clock genes
× stress × reward interactions in alcohol and substance use
disorders. Alcohol. 49:351–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Saad L, Zwiller J, Kalsbeek A and Anglard
P: Epigenetic regulation of circadian clocks and its involvement in
drug addiction. Genes (Basel). 12:12632021. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lewis RG, Florio E, Punzo D and Borrelli
E: The Brain's reward system in health and disease. Adv Exp Med
Biol. 1344:57–69. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wittenberg RE, Wolfman SL, De Biasi M and
Dani JA: Nicotinic acetylcholine receptors and nicotine addiction:
A brief introduction. Neuropharmacology. 177:1082562020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Jiloha RC: Biological basis of tobacco
addiction: Implications for smoking-cessation treatment. Indian J
Psychiatry. 52:301–307. 2010. View Article : Google Scholar
|
|
98
|
Reiter RJ, Mayo JC, Tan DX, Sainz RM,
Alatorre-Jimenez M and Qin L: Melatonin as an antioxidant: Under
promises but over delivers. J Pineal Res. 61:253–278. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Datta PC and King MG: Melatonin: Effects
on brain and behavior. Neurosci Biobehav Rev. 4:451–458. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Fatemeh G, Sajjad M, Niloufar R, Neda S,
Leila S and Khadijeh M: Effect of melatonin supplementation on
sleep quality: A systematic review and meta-analysis of randomized
controlled trials. J Neurol. 269:205–216. 2022. View Article : Google Scholar
|
|
101
|
Foley HM and Steel AE: Adverse events
associated with oral administration of melatonin: A critical
systematic review of clinical evidence. Complement Ther Med.
42:65–81. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Motooka Y, Matsui T, Slaton RM, Umetsu R,
Fukuda A, Naganuma M, Hasegawa S, Sasaoka S, Hatahira H, Iguchi K
and Nakamura M: Adverse events of smoking cessation treatments
(nicotine replacement therapy and non-nicotine prescription
medication) and electronic cigarettes in the food and drug
administration adverse event reporting system, 2004-2016. SAGE Open
Med. 6:20503121187779532018. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Erland LAE and Saxena PK: Melatonin
natural health products and supplements: Presence of serotonin and
significant variability of melatonin content. J Clin Sleep Med.
13:275–281. 2017. View Article : Google Scholar :
|
|
104
|
Liu J, Clough SJ, Hutchinson AJ,
Adamah-Biassi EB, Popovska-Gorevski M and Dubocovich ML: MT1 and
MT2 melatonin receptors: A therapeutic perspective. Annu Rev
Pharmacol Toxicol. 56:361–383. 2016. View Article : Google Scholar :
|
|
105
|
Giulietti F, Filipponi A, Rosettani G,
Giordano P, Iacoacci C, Spannella F and Sarzani R: Pharmacological
approach to smoking cessation: An updated review for daily clinical
practice. High Blood Press Cardiovasc Prev. 27:349–362. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Perkins KA, Conklin CA and Levine MD:
Cognitive-behavioral therapy for smoking cessation: A practical
guidebook to the most effective treatments. 1st edition. Routledge;
New York, NY: 2007
|
|
107
|
Shirani A and St Louis EK: Illuminating
rationale and uses for light therapy. J Clin Sleep Med. 5:155–163.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Patterson F, Grandner MA, Malone SK, Rizzo
A, Davey A and Edwards DG: Sleep as a target for optimized response
to smoking cessation treatment. Nicotine Tob Res. 21:139–148. 2019.
View Article : Google Scholar :
|
|
109
|
Silva ACPE, Santos MJD, Koike BDV, Moreira
MSA, Gitai DLG, de Miranda Coelho JAP and de Andrade TG: Melatonin
receptor 1B-1193T>C polymorphism is associated with diurnal
preference and sleep habits. Sleep Med. 53:106–114. 2019.
View Article : Google Scholar
|
|
110
|
Sulkava S, Ollila HM, Alasaari J, Puttonen
S, Härmä M, Viitasalo K, Lahtinen A, Lindström J, Toivola A,
Sulkava R, et al: Common genetic variation near melatonin receptor
1A gene linked to job-related exhaustion in shift workers. Sleep.
40:zsw0112017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Pandi-Perumal SR, Zisapel N, Srinivasan V
and Cardinali DP: Melatonin and sleep in aging population. Exp
Gerontol. 40:911–925. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Shechter A and Boivin DB: Sleep, hormones,
and circadian rhythms throughout the menstrual cycle in healthy
women and women with premenstrual dysphoric disorder. Int J
Endocrinol. 2010:2593452010. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Leventhal AM, Waters AJ, Boyd S, Moolchan
ET, Lerman C and Pickworth WB: Gender differences in acute tobacco
withdrawal: Effects on subjective, cognitive, and physiological
measures. Exp Clin Psychopharmacol. 15:21–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Repova K, Baka T, Krajcirovicova K, Stanko
P, Aziriova S, Reiter RJ and Simko F: Melatonin as a potential
approach to anxiety treatment. Int J Mol Sci. 23:161872022.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Touitou Y, Reinberg A and Touitou D:
Association between light at night, melatonin secretion, sleep
deprivation, and the internal clock: Health impacts and mechanisms
of circadian disruption. Life Sci. 173:94–106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
English J, Arendt J, Poulton A and Symons
AM: Short-term variations of circulating melatonin in the ewe. J
Pineal Res. 4:359–366. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Cozzi B, Ravault JP, Ferrandi B and Reiter
RJ: Melatonin concentration in the cerebral vascular sinuses of
sheep and evidence for its episodic release. J Pineal Res.
5:535–543. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Rzepka-Migut B and Paprocka J:
Melatonin-measurement methods and the factors modifying the
results. A systematic review of the literature. Int J Environ Res
Public Health. 17:19162020. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Benloucif S, Burgess HJ, Klerman EB, Lewy
AJ, Middleton B, Murphy PJ, Parry BL and Revell VL: Measuring
melatonin in humans. J Clin Sleep Med. 4:66–69. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Florescu A, Ferrence R, Einarson T, Selby
P, Soldin O and Koren G: Methods for quantification of exposure to
cigarette smoking and environmental tobacco smoke: Focus on
developmental toxicology. Ther Drug Monit. 31:14–30. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Tordjman S, Chokron S, Delorme R, Charrier
A, Bellissant E, Jaafari N and Fougerou C: Melatonin: pharmacology,
functions and therapeutic benefits. Curr Neuropharmacol.
15:434–443. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Valentine JA: The transformative role of
authentic partnership in the tuskegee public health ethics program.
J Healthc Sci Humanit. 8:21–29. 2018.PubMed/NCBI
|
|
123
|
Minichino A, Bersani FS, Calò WK, Spagnoli
F, Francesconi M, Vicinanza R, Delle Chiaie R and Biondi M: Smoking
behaviour and mental health disorders-mutual influences and
implications for therapy. Int J Environ Res Public Health.
10:4790–4811. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Caruana EJ, Roman M, Hernández-Sánchez J
and Solli P: Longitudinal studies. J Thorac Dis. 7:E537–E540.
2015.PubMed/NCBI
|
|
125
|
Yip C, Han NR and Sng BL: Legal and
ethical issues in research. Indian J Anaesth. 60:684–688. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Faber J and Fonseca LM: How sample size
influences research outcomes. Dental Press J Orthod. 19:27–29.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Hariton E and Locascio JJ: Randomised
controlled trials-the gold standard for effectiveness research:
Study design: Randomised controlled trials. BJOG. 125:17162018.
View Article : Google Scholar
|
|
128
|
Lim CY and In J: Considerations for
crossover design in clinical study. Korean J Anesthesiol.
74:293–299. 2021. View Article : Google Scholar : PubMed/NCBI
|
